Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- CheckyesterdayChange DetectedThe study record history shows a new revision tag (v3.6.4) and removal of the previous v3.6.3, indicating an updated page version.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s revision label updated from v3.6.2 to v3.6.3, indicating a minor site version update.SummaryDifference0.0%

- Check30 days agoChange DetectedThe footer revision label changed from v3.6.0 to v3.6.2, indicating a site revision or update rather than substantive content changes. This maintenance update does not alter core study information.SummaryDifference0.0%

- Check44 days agoChange DetectedAdds 'No longer looking for participants' to indicate recruitment status has changed. Updates the history with 'Revision: v3.6.0' and removes the previous 'Revision: v3.5.5' label to reflect the latest version of the study record.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page history now shows Revision: v3.5.5 replacing Revision: v3.5.4. This reflects a minor site version update and does not affect the clinical trial data or page content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe study record advances to a new version (v3.5.4) with an 'Active, not recruiting' status and updated Study Status, Recruitment Status, and Contacts/Locations, replacing the previous 'Recruiting' state from v3.5.3.SummaryDifference0.4%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.